2012 focused update of the ESC Guidelines for the management of atrial fibrillation: an update of the 2010 ESC Guidelines for the management of atrial fibrillation. Developed with the special contribution of the European Heart Rhythm Association.
Explore this paper's citation graph
Summary
A prospective, randomized, double blind, Active-controlled, superiority study of Vernakalant vs. amiodarone in Recent Onset atrial fibrillation for the prevention of cardiovascular Hospitalization or death from any cause.
- Type
- article
- Published
- 2012-11-01
- Cited by
- 3,052
- References
- 195
- Access
- Open access
- OpenAlex
- https://openalex.org/W3030533492
- Semantic Scholar
- https://api.semanticscholar.org/CorpusID:7455535
Keywords
Medicine, Atrial fibrillation, Management of atrial fibrillation, Intensive care medicine, Cardiology
References
- Conversion efficacy and safety of intravenous ibutilide compared with intravenous procainamide in patients with atrial flutter or fibrillation.
- Early and comprehensive management of atrial fibrillation: proceedings from the 2nd AFNET/EHRA consensus conference on atrial fibrillation entitled 'research perspectives in atrial fibrillation'.
- CHADS(2) and CHA(2)DS(2)-VASc scores in the prediction of clinical outcomes in patients with atrial fibrillation after catheter ablation.
- Atrial fibrillation: the rate versus rhythm management controversy.
- Catheter ablation for atrial fibrillation: are results maintained at 5 years of follow-up?
- Performance of the HEMORR(2)HAGES, ATRIA, and HAS-BLED bleeding risk-prediction scores in patients with atrial fibrillation undergoing anticoagulation: the AMADEUS (evaluating the use of SR34006 compared to warfarin or acenocoumarol in patients with atrial fibrillation) study.
- Incidence of asymptomatic intracranial embolic events after pulmonary vein isolation: comparison of different atrial fibrillation ablation technologies in a multicenter study.
- Relationships Between Sinus Rhythm, Treatment, and Survival in the Atrial Fibrillation Follow-Up Investigation of Rhythm Management (AFFIRM) Study
- Bleeding risk in ‘real world’ patients with atrial fibrillation: comparison of two established bleeding prediction schemes in a nationwide cohort
- Stroke in atrial fibrillation: epidemiology and thromboprophylaxis
- A New Risk Scheme to Predict Warfarin-Associated Hemorrhage: The AnTicoagulation and Risk Factors In Atrial Fibrillation (ATRIA) Study
- Pulmonary Vein Antrum Isolation for Atrial Fibrillation on Therapeutic Coumadin: Special Considerations
- A comparison of risk stratification schemes for stroke in 79 884 atrial fibrillation patients in general practice
- Bleeding risk assessment and management in atrial fibrillation patients
- Feasibility and safety of dabigatran versus warfarin for periprocedural anticoagulation in patients undergoing radiofrequency ablation for atrial fibrillation: results from a multicenter prospective registry.
- Questions and answers on the use of dabigatran and perpectives on the use of other new oral anticoagulants in patients with atrial fibrillation.
- Oral anticoagulation use by patients with atrial fibrillation in Germany
- Effect of non-specific reversal agents on anticoagulant activity of dabigatran and rivaroxaban
- Comprehensive risk reduction in patients with atrial fibrillation: Emerging diagnostic and therapeutic options
- Consensus Document: Antithrombotic therapy in patients with atrial fibrillation undergoing coronary stenting
Cited by
- Percutaneous left atrial appendage closure: procedural techniques and outcomes.
- Management des Vorhofflimmerns
- La fibrillation atriale chez la personne âgée: déterminants de la prescription d’anticoagulants. Étude originale réalisée chez 170 résidents d’EHPAD
- Triple antithrombotic therapy versus double antiplatelet therapy after percutaneous coronary intervention with stent implantation in patients requiring chronic oral anticoagulation: a meta‐analysis
- Atrial fibrillation: state of the art
- Left atrial appendage and thromboembolism: Shape matters.
- Questionable levels of evidence in new atrial fibrillation guidelines? Reply.
- A specialized atrial fibrillation clinic: improving care and costs for patients with atrial fibrillation.
- Recent developments in understanding epidemiology and risk determinants of atrial fibrillation as a cause of stroke.
- Antithrombotic and antiplatelet therapy in TAVI patients: a fallow field?
- Multidetector computed tomography may be an adequate screening test to reduce periprocedural stroke in atrial fibrillation ablation: a multicenter propensity-matched analysis.
- Hypercoagulability, D-dimer and atrial fibrillation: an overview of biological and clinical evidence
- Educating orally anticoagulated patients in drug safety: a cluster-randomized study in general practice.
- Prognostic implications of arrhythmias during primary percutaneous coronary interventions for ST-elevation myocardial infraction
- Novel oral anticoagulants and valvular atrial fibrillation: are they always contraindicated?
- Impact of advanced age on management and prognosis in atrial fibrillation: insights from a population-based study in general practice.
- Effects of new class III antiarrhythmic drug niferidil on electrical activity in murine ventricular myocardium and their ionic mechanisms
- Impact of Sex Difference on Severity and Functional Outcome in Patients with Cardioembolic Stroke.
- Efficacy of Oral Anticoagulation in Stroke Prevention among Sinus-Rhythm Patients Who Lack Left Atrial Mechanical Contraction after Cryoablation.
- Clinical Cardiology, Geriatric Cardiology, Heart Failure, and Transplantation 2015: A Selection of Topical Issues.
Related papers
- DETERMINING QUALITY REQUIREMENTS AT THE UNIVERSITIES TO IMPROVE THE QUALITY OF EDUCATION
- Emergency management of atrial fibrillation
- Evolving perspectives for personalised management of patients with atrial fibrillation
- [Therapeutic approach to the epidemic of atrial fibrillation].
- Atrial fibrillation: management strategies in the emergency department.
- Overview of Management of Atrial Fibrillation in Symptomatic Elderly Patients: Pharmacologic Therapy Versus AV Node Ablation
- Anticoagulation in atrial fibrillation
- Management of atrial fibrillation.